Please login to the form below

Not currently logged in
Email:
Password:

CoStim Pharmaceuticals

This page shows the latest CoStim Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Novartis enters PD-1 race via CoStim acquisition

Novartis enters PD-1 race via CoStim acquisition

Novartis enters PD-1 race via CoStim acquisition. Expands presence in cancer immunotherapies. ... Novartis has reached a deal to acquire US company CoStim Pharmaceuticals, expanding its position in the hot topic of cancer immunotherapy.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics